PMC:7212965 / 41386-41651 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T214","span":{"begin":63,"end":79},"obj":"Disease"},{"id":"T216","span":{"begin":122,"end":128},"obj":"Disease"}],"attributes":[{"id":"A214","pred":"mondo_id","subj":"T214","obj":"http://purl.obolibrary.org/obo/MONDO_0000605"},{"id":"A215","pred":"mondo_id","subj":"T214","obj":"http://purl.obolibrary.org/obo/MONDO_0005271"},{"id":"A216","pred":"mondo_id","subj":"T216","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"tion: Rare elevations in aminotransferases. Most reactions are hypersensitivity with no known cross reactivity to hepatic injury. If this occurs, reasonable to switch between chloroquine therapies. Substrate for CYP2D6 and CYP3A4 substrateSame as above; also substr"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T94","span":{"begin":175,"end":186},"obj":"Chemical"}],"attributes":[{"id":"A94","pred":"chebi_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"tion: Rare elevations in aminotransferases. Most reactions are hypersensitivity with no known cross reactivity to hepatic injury. If this occurs, reasonable to switch between chloroquine therapies. Substrate for CYP2D6 and CYP3A4 substrateSame as above; also substr"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T192","span":{"begin":63,"end":79},"obj":"Phenotype"}],"attributes":[{"id":"A192","pred":"hp_id","subj":"T192","obj":"http://purl.obolibrary.org/obo/HP_0041092"}],"text":"tion: Rare elevations in aminotransferases. Most reactions are hypersensitivity with no known cross reactivity to hepatic injury. If this occurs, reasonable to switch between chloroquine therapies. Substrate for CYP2D6 and CYP3A4 substrateSame as above; also substr"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T12","span":{"begin":63,"end":79},"obj":"http://purl.obolibrary.org/obo/GO_0002524"}],"text":"tion: Rare elevations in aminotransferases. Most reactions are hypersensitivity with no known cross reactivity to hepatic injury. If this occurs, reasonable to switch between chloroquine therapies. Substrate for CYP2D6 and CYP3A4 substrateSame as above; also substr"}

{"project":"LitCovid-sentences","denotations":[{"id":"T262","span":{"begin":6,"end":43},"obj":"Sentence"},{"id":"T263","span":{"begin":44,"end":129},"obj":"Sentence"},{"id":"T264","span":{"begin":130,"end":197},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"tion: Rare elevations in aminotransferases. Most reactions are hypersensitivity with no known cross reactivity to hepatic injury. If this occurs, reasonable to switch between chloroquine therapies. Substrate for CYP2D6 and CYP3A4 substrateSame as above; also substr"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1072","span":{"begin":212,"end":218},"obj":"Gene"},{"id":"1073","span":{"begin":223,"end":229},"obj":"Gene"},{"id":"1090","span":{"begin":175,"end":186},"obj":"Chemical"},{"id":"1097","span":{"begin":63,"end":79},"obj":"Disease"},{"id":"1098","span":{"begin":114,"end":128},"obj":"Disease"}],"attributes":[{"id":"A1072","pred":"tao:has_database_id","subj":"1072","obj":"Gene:1565"},{"id":"A1073","pred":"tao:has_database_id","subj":"1073","obj":"Gene:1576"},{"id":"A1090","pred":"tao:has_database_id","subj":"1090","obj":"MESH:D002738"},{"id":"A1097","pred":"tao:has_database_id","subj":"1097","obj":"MESH:D004342"},{"id":"A1098","pred":"tao:has_database_id","subj":"1098","obj":"MESH:D056486"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tion: Rare elevations in aminotransferases. Most reactions are hypersensitivity with no known cross reactivity to hepatic injury. If this occurs, reasonable to switch between chloroquine therapies. Substrate for CYP2D6 and CYP3A4 substrateSame as above; also substr"}